Flavonoids, previously proposed anti-cancer agents thus emerge as direct inhibitors of TPC2 and the higher risk for blond haired individuals or individuals with light pigmentation to develop melanoma may be directly correlated to TPC2 activity and GOF variation. The gene discussed is TPCN2; the disease is melanoma.